The investigation determined that lower than expected quality control results obtained from a non-vitros biorad quality control (qc) fluid when using vitros immunodiagnostics products psa (psa) reagent in combination with two vitros xt 7600 integrated systems.A definitive assignable cause for the lower than expected vitros psa results could not be determined with the information provided.No information was provided with regards to the handling of the qc samples between vitros psa testing events.It is possible improper handling of the qc samples contributed to the lower than expected vitros psa lot 4290 results, although this could not be confirmed.Instrument related performance issues did not likely contribute to the events as the customer gave no indication of any instrument malfunction however, as no diagnostic within run precision testing was performed, an instrument issue cannot be completely ruled out as a potential contributor to the event.Ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros psa lot 4290.
|